Deepti Shetty

Co-Founder & COO

The MedTech industry is entering a transformative phase as healthcare systems worldwide confront the growing burden of chronic diseases. Rising cases of diabetes, hypertension, and aging populations are driving a steady increase in kidney failure, placing enormous pres­sure on dialysis infrastructure.

At the same time, healthcare providers are actively seeking ways to decentralize care, re­duce infrastructure dependency, and bring treatment clos­er to patients. While peritoneal dialysis (PD) has long been considered a viable home-based therapy, the operational ar­chitecture supporting it has remained largely unchanged for decades.

Dependence on centralized dialysate manufacturing and large-volume supply chains continues to create logistical and clinical limitations. In this evolving healthcare landscape, MedKern is positioning itself as a pioneering innovator by re­thinking dialysis delivery through KarePD, a next-generation point-of-care peritoneal dialysis platform designed to make therapy more scalable, intelligent, and accessible.

Re-engineering Peritoneal Dialysis for the Point-of-Care Era

Peritoneal dialysis is clinically well suited for home therapy, yet the infrastructure supporting it still reflects a legacy model built around centralized manufacturing and distribution of dialysate fluid. This reliance on large volumes of pre-manufactured dialysate creates operational challenges, particularly in geographies with infrastructure limitations.

Patients must depend on continuous supply chains for delivery and storage, while prescription flexibility can sometimes be influenced by supply availability rather than individual patient needs.

MedKern's KarePD platform seeks to fundamentally transform this architecture by enabling on-demand dialysate preparation directly at the point-of-care. Instead of relying on pre-manufactured fluids, KarePD prepares dialysis fluid using tap water through a multi-stage purification system combined with precision micro-dosing of electrolytes and osmotic agents.

The platform aligns with pharmacopeial water standards and validates key fluid parameters before therapy delivery, ensuring safety and clinical reliability.

This approach significantly reduces the logistical burden associated with dialysate supply chains while creating opportunities for more flexible therapy delivery. By shifting dialysate preparation to the patient’s location, KarePD moves peritoneal dialysis closer to a truly decentralized care model, one that can be more easily scaled across both developed and infrastructure-constrained healthcare environments.

An Intelligent Platform for Data-Driven Dialysis Care

While the logistics of dialysate preparation represent a major operational challenge, another critical gap in the dialysis ecosystem lies in clinical visibility. Patients performing peritoneal dialysis at home typically manage therapy independently, yet clinical oversight remains intermittent.

Physicians often rely on retrospective logs reviewed during periodic consultations, which can delay the detection of therapy deviations, infection risks, or declining treatment performance.

MedKern addresses this challenge through an integrated intelligent control layer within KarePD. The system incorporates sensors that continuously monitor key parameters including flow, pressure, conductivity, temperature, and turbidity.

Rather than simply recording passive therapy data, the platform is designed to detect deviations and generate early warning signals that can support clinicians in identifying emerging complications or therapy irregularities.

In addition to its monitoring capabilities, KarePD introduces a gravity-independent therapy delivery system driven by in-house engineered pumps and control mechanisms.

The cassette-free design supports both short and long dwell prescriptions while allowing precise control over fluid movement. Importantly, the system is battery operable and engineered to function in environments where infrastructure reliability may vary.

Through this integration of fluid preparation, automated delivery, and intelligent monitoring, KarePD transforms peritoneal dialysis into a more responsive and data-informed therapy platform.

By enabling earlier intervention and improved clinical insight, the technology has the potential to strengthen both patient confidence and physician decision-making in home dialysis care.

Building Global-Grade MedTech Innovation from India

Behind MedKern's technological platform lies a development philosophy rooted in engineering rigor and regulatory discipline. From the earliest stages of product development, the company has embedded safety, traceability, and risk management into its architecture.

Rather than treating regulatory compliance as a downstream requirement, MedKern has prioritized alignment with global standards from the outset, working closely with experienced regulatory advisors and nephrology experts.

The company’s founder, Uttam, brings expertise from precision motor systems and drone engineering, fields where reliability, stability, and performance optimization are essential. This background has influenced MedKern's engineering culture, particularly in areas such as miniaturization, control precision, and system integration.

Several critical subsystems, including brushless motors and control electronics are designed and manufactured in-house, allowing the team to maintain tighter control over performance characteristics and product scalability.

MedKern is also deeply aligned with India’s rapidly evolving deep-tech ecosystem. Support from organizations such as C-CAMP, the Bangalore Bioinnovation Center (BBC), and SCTIMST–TiMED has provided important guidance in areas ranging from regulatory pathways to clinical collaboration.

The company has also benefited from government-supported initiatives, including TIDES at IIT Roorkee under the Startup India Seed Fund Scheme.

Looking ahead, MedKern is advancing toward clinical validation through a structured development roadmap aligned with the Indian CDSCO regulatory pathway. Early subsystem validation, risk analysis, and verification testing are already underway as the company prepares for supervised clinical studies.

These studies are expected to generate robust evidence around safety, usability, and therapy performance, helping establish confidence within the nephrology community.

MedKern envisions a future where peritoneal dialysis becomes a digitally connected, point-of-care therapy capable of operating across diverse healthcare environments. As dialysis systems worldwide move toward decentralization, technologies like KarePD may play an important role in bridging the gap between clinical need and operational feasibility.

By combining precision engineering, intelligent monitoring, and a commitment to scalable healthcare design, MedKern is demonstrating how globally competitive medical technology can be engineered in India and delivered to patients around the world.